|

Home / Research / Publications / AR copy number amplification and AR/KLK3 expression patterns reveal mechanisms of AR signaling inhibitor (ARSI) resistance and highlight the need for AR-directed therapeutic innovation in metastatic castration resistance prostate cancer (mCRPC)

Publications

AR copy number amplification and AR/KLK3 expression patterns reveal mechanisms of AR signaling inhibitor (ARSI) resistance and highlight the need for AR-directed therapeutic innovation in metastatic castration resistance prostate cancer (mCRPC)

Key Findings:

  • AR alterations and AR/KLK3 expression were evaluated in mCRPC and correlated with treatment outcomes. 
  • AR copy number amplification (CNA) was associated with increased AR signaling and shorter time on treatment with ARSIs. 
  • These findings support a role for transcriptionally active AR in CNA-driven resistance. 
Download Publication
Learn More